Floatz logo

Immunoglobulin G1 [301-alanine,de-C-terminal-lysine], anti-(human CD73 antigen) (human-Mus musculus monoclonal INCA00186 ?1-chain), disulfide with human-Mus musculus monoclonal INCA00186 ?-chain, dimer

Gastrointestinal (GI) Malignancies

Incyte Corporationmonoclonal_antibodyPhase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

43 Active assets in the Gastrointestinal (GI) Malignancies cohort.

Asset / SponsorPhaseRating
Capecitabine
China Medical University, China
Phase 3BB
Sorafenib
Sichuan Cancer Hospital and Research Institute
Phase 3BB
Irinotecan
Pfizer
Phase 3BB
FLUOROURACILUM
Janssen Research & Development, LLC
Phase 3BB
pf-08634404
Pfizer
Phase 3B

View all 50 →

Same molecule, other indications

Immunoglobulin G1 [301-alanine,de-C-terminal-lysine], anti-(human CD73 antigen) (human-Mus musculus monoclonal INCA00186 ?1-chain), disulfide with human-Mus musculus monoclonal INCA00186 ?-chain, dimer is also rated in:

head and neck squamous cell carcinomaDormant
CC
Indicative ·
43 / 100
View asset →
cancerDormant
C
Indicative ·
36 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →